| Stage | FRD | % of rev | CRWS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $240M | 100.00% | $17M | 100.00% | FRD ×14.31 |
| Gross profit | $42M | 17.64% | $8M | 47.90% | CRWS +30.3pp |
| Operating income | $21M | 8.77% | $3M | 16.69% | CRWS +7.9pp |
| Pre-tax income | $17M | 7.07% | $3M | 16.55% | CRWS +9.5pp |
| Net income | $13M | 5.33% | $2M | 12.29% | CRWS +7.0pp |
| Stage | FRD | CRWS | Gap · A − B |
|---|---|---|---|
| Revenue | $240M100.00% | $17M100.00% | FRD ×14.31 |
| Gross profit | 17.64%$42M | 47.90%$8M | CRWS +30.3pp |
| Operating income | 8.77%$21M | 16.69%$3M | CRWS +7.9pp |
| Pre-tax income | 7.07%$17M | 16.55%$3M | CRWS +9.5pp |
| Net income |
| 5.33%$13M |
| 12.29%$2M |
| CRWS +7.0pp |
No shared counterparties.